More on TNGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-150.0% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tango Therapeutics, Inc (NQ:TNGX)
Delayed: 24.30 -0.62 (2.49%)
Prev. Close $24.92  
Open$24.92 
52 Wk High$ 
52 Wk Low$ 
Day High$24.92 
Day Low$23.70 
P/E N/A  
EPS$ 
Volume2,413,504 

Friends, Peers and Foes (?): ABBV, ONCY, TEVA, NUVL, PRAX (more...)

Sep 24, 2026 07:42 PM Form 4 Tango Therapeutics, Inc. For: Sep 22 Filed by: Newcomb Jessica
Sep 22, 2026 04:14 PM Form 144 Tango Therapeutics, Inc. Filed by: Newcomb Jessica
Sep 3, 2026 04:05 PM Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 1, 2026 07:00 AM Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Aug 18, 2026 06:39 AM Tango Therapeutics Inc. (TNGX) PT Raised to $68 at H.C. Wainwright
Aug 17, 2026 07:49 AM Tango Therapeutics Inc. (TNGX) Reiterated at Buy by Stifel: 3 Catalysts by YE26
Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.
Aug 14, 2026 04:20 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Aug 14, 2026 02:12 PM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: GOLDMAN SACHS GROUP INC
Aug 14, 2026 11:05 AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP
View All Articles

Entities mentioned with tngx

View All Entities